Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

Morinaga Milk Expands Lactoferrin Production Capacity in German Subsidiary “MILEI GmbH”

2020-10-29 13:39:00

TOKYO--()--Morinaga Milk Industry Co., Ltd. (TOKYO: 2264) (hereafter, “Morinaga Milk”) hereby announces that its subsidiary MILEI GmbH (hereafter, “MILEI”), which has the largest share* of the global market in terms of production volume of the functional ingredient lactoferrin, will increase more than double its production capacity with the aim to enhance its lactoferrin production.
* According to data for 2019 released by Absolute Reports

1. Overview

(1) Location: Kemptener Strasse 91, 88299 Leutkirch, Germany
(2) Product manufactured: Lactoferrin
(3) Total investment: EUR 15,000,000 (approx. JPY 1.8 billion*) * Assuming an exchange rate of 120 yen to one euro
(4) Production capacity: Approx. 170 tons (more than double that of fiscal 2019)
(5) Launch of operations: April 2021 (planned)

2. Background and purpose

As a functional ingredient for infant formula, supplements and other foods, the demand for lactoferrin has been growing particularly in Western countries and Asia.
Considering the increasing attention towards health and nutrition, the demand for lactoferrin as a functional ingredient with health value is expected to grow over the long term globally.
Morinaga Milk Group considers lactoferrin as an important functional ingredient to support people’s health and nutrition worldwide and has been conducting fundamental research and seeking commercial applications for over six decades.
Morinaga Milk Group is aiming to increase the sales of its own lactoferrin-related products with expanding production capacity in MILEI, and will flexibly respond to the long-term increasing demand of lactoferrin.
Having the largest production share of lactoferrin, Morinaga Milk Group will increase the production of MILEI and contribute to the well-being of people.

3. Effect on financial results

The investment will not affect financial results for the fiscal year ending March 31, 2021.

[Reference information]

MILEI GmbH

MILEI is based in the southern German city of Leutkirch, where its production facilities are located.
Founded in 1972, MILEI has a history of almost five decades since its start of production in 1975. MILEI offers lactoferrin, whey protein concentrate, lactose and other dairy ingredients mainly in Europe and Asia. Many companies, including global food manufacturers, use MILEI’s ingredients for infant formula, sports nutrition and others. Under the global strategy of Morinaga Milk, MILEI plays an important role supporting production and sales of ingredients for infant formula, supplements and others.

Lactoferrin

Present in most exocrine secretions such as breast milk and saliva of humans and other mammals, lactoferrin is a component with a wide range of physiological functions. The high amount of lactoferrin found in human breast milk, especially in colostrum, is considered to offer important and protective benefits to newborns.
Discovered by Danish scientists in 1939, lactoferrin as a remarkable functional ingredient, has been intensively researched by scientists worldwide, as shown by the increasing number of the studies in the graph (Figure 1). Paying high attention to the fact that lactoferrin is highly abundant in colostrum, Morinaga Milk has been focusing its research efforts on lactoferrin over the long term to develop infant formula that closely resembles breast milk. Since its initial publication of a research paper on lactoferrin in 1963, Morinaga Milk has been reporting its benefits through academic forums, conferences and publications.

Contacts

International Division, Morinaga Milk Industry Co., Ltd.
Yoshihiko Ushida
Tamami Shibata
TEL: +81-3-3798-0152
E-mail: interntl@morinagamilk.co.jp
https://www.morinagamilk.co.jp/english/
https://www.milei.de (MILEI GmbH Website)

Powdered lactoferrin (Photo: Morinaga Milk)

(Photo: Morinaga Milk)

Figure 1 "Number of Academic Papers on Lactoferrin Published Worldwide from 1961 to 2020" (Source:PubMed.gov “lactoferrin”)

Link

Interfax Business Wire

2020-11-30
14:17:00
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds JOYY Inc. Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm – YY
10:55:00
Kaneka Develops Super Heat-Resistant Polyimide Film for 5G Millimeter Wave Zones
09:35:00
Last and Final Victory for Sisvel Before the German Federal Supreme Court (BGH) In the Sisvel vs Haier Cases
2020-11-27
18:11:00
Leveraging Its Mobile ID, IDEMIA Brings Digital Travel Credentials to Life
16:18:00
Elliptic Labs Launches with Xiaomi’s Mass-Volume Smartphone Redmi Note 9 Pro Smartphones
16:01:00
DEWA Innovation Centre and 800MW 3rd Phase of the Mohammed bin Rashid Al Maktoum Solar Park Inaugurated
15:56:00
Saudi Urban20 Chair Wishes Italy ‘Buona Fortuna’ With the 2021 Urban20 Presidency
14:14:00
ViacomCBS to Sell Simon & Schuster to Penguin Random House for $2.175 Billion
13:22:00
Fitbit and JMDC Sign Agreement to Appoint JMDC as Exclusive Distributor of Fitbit Premium for Enterprise Customers in Japan
09:31:00
Defense Innovation Unit (DIU) Selects Immervision InnovationLab to Develop a Computer Vision Wide Angle Camera for the Blue UAS Framework Project
2020-11-26
17:51:00
Mavenir and Airtel Demonstrate O-RAN RIC (RAN Intelligent Controller) at Global O-RAN ALLIANCE Plugfest hosted by Airtel in India
16:29:00
Northern Data AG Commissions First Data Center in the Netherlands
16:27:00
Faraday Supplies 28eHV Memory Compilers for Mobile OLED Display Driver IC
15:10:00
Advanced Technology Research Council Announces ‘ASPIRE’ – to Drive the Creation of Future Transformative Technologies
14:15:00
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
13:30:00
WTA and Stats Perform Serve up Breakthrough Tennis AI and Data Partnership, in Landmark Deal for Women’s Sports
12:00:00
Moody’s Analytics Earns #2 Overall Ranking in Chartis RiskTech100®
09:25:00
The Open Group and International Telecommunication Union Collaborate to Develop Digital Government Strategies
09:16:00
MEDIROM Healthcare Technologies Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering on NASDAQ
2020-11-25
18:47:00
Local Governments Realize ExaGrid Offers Exceptional Backup Storage
Back to Top